The provided text details the financial statements and performance of The Procter & Gamble Company and its subsidiaries, covering various aspects such as net sales, earnings, comprehensive income, balance sheets, shareholders' equity, and cash flow. It also includes information on segments, goodwill, intangible assets, earnings per share, share-based compensation, risk management activities, commitments and contingencies, and legal matters. The data in the text provides a comprehensive overview of the company's financial health, operations, and accounting practices for the periods noted.
The text discusses the forward-looking statements, risks, and uncertainties related to financial conditions and operations, providing an overview of Procter & Gamble's business segments, financial results, and market environment. It highlights the company's sales percentages by segment and key financial results for the six months ending December 31, 2021, such as a 3% increase in net earnings to $8.3 billion. The different business segments like Beauty, Grooming, and Health Care saw sales increases, with the Beauty segment experiencing a 3% rise driven by volume growth and higher pricing. Additionally, the text addresses the company's exposure to global economic conditions, changing costs, foreign exchange fluctuations, and COVID-19 impacts, discussing how these factors influence their operations. Management's Discussion and Analysis (MD&A) supplements the consolidated financial statements by providing insights into performance evaluation measures used, like organic sales growth and market share estimates.
No material changes occurred in the Company's market risk exposure since June 30, 2021. More details can be located in Note 7 of the Consolidated Financial Statements.
The Company's President and Chief Executive Officer, Jon R. Moeller, and Chief Financial Officer, Andre Schulten, evaluated the Company's disclosure controls and procedures, reporting them as effective in ensuring timely and accurate disclosure. Additionally, there were no changes in the internal control over financial reporting during the fiscal quarter that significantly affected or are likely to affect the Company.
The Company discusses legal proceedings and claims it faces in various areas such as antitrust, product liability, contracts, and more. SEC regulations mandate disclosure of environmental proceedings when governmental authorities are involved and monetary sanctions exceeding a certain threshold are expected. However, for the current period, there are no relevant matters to disclose under this item.
The text advises to refer to the "Risk Factors" section in Part I, Item 1A of the Company's Form 10-K for the year ended June 30, 2021, for information on risk factors.
The text provided outlines the unregistered sales of equity securities by a company over the period from October 1, 2021, to December 31, 2021. During this period, the company purchased a total of 31,410,184 shares with an average price of $151.23 per share. The company made these purchases as part of a publicly announced plan to reduce outstanding shares through direct share repurchases in the fiscal year 2022, with an expected value of $9 to $10 billion. The share repurchases are authorized by the company's Board of Directors and are expected to be financed through a combination of operating cash flows and the issuance of long-term and short-term debt.
I'm here to help. Please go ahead and provide the text that needs to be summarized.
I apologize, but I am unable to assist with providing a summary as there was no text provided for me to summarize. Would you like to provide the text for me to summarize?
I'm sorry, but it seems like there was some miscommunication. I am unable to receive any text from you as a reference for summarization. Could you please provide the text that you would like me to summarize directly in your message?
The provided text primarily consists of a list of exhibits associated with a company, including documents such as amended articles of incorporation, regulations, indentures, and certifications for company officers. It also mentions the submission of various documents regarding the company's separation agreements and certification requirements in line with regulatory rules. The content emphasizes the detailed listing of various documents and exhibits filed by the company, with references to their respective annual reports and the specific forms they were included in.
